Skip to main content
Indoco Remedies Ltd. logo

Indoco Remedies Ltd. — Investor Relations & Filings

Ticker · INDOCO ISIN · INE873D01024 LEI · 3358007XE9RRPHJA6U47 BSE.NS Manufacturing
Open in API
Filings indexed 772 across all filing types
Latest filing 2025-02-12 Regulatory Filings
Country IN India
Listing BSE.NS INDOCO

About Indoco Remedies Ltd.

https://www.indoco.com/

Indoco Remedies Ltd. is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of finished dosages and Active Pharmaceutical Ingredients (APIs). The company operates multiple manufacturing facilities equipped to produce various dosage forms, including tablets, capsules, injectables, ophthalmics, and topical preparations. Its therapeutic portfolio spans stomatologicals, anti-infectives, respiratory, cardiovascular, anti-diabetics, and pain management. Indoco maintains a significant global footprint, exporting products to over 55 countries, including highly regulated markets such as the United States and Europe. The organization is recognized for its strong research and development capabilities, focusing on complex generics and niche formulations. Key brands include Sensodent-K, Febrex Plus, and Cyclopam, reflecting its leadership in specific therapeutic segments.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the National Stock Exchange of India Limited and Bombay Stock Exchange Limited. It discloses information pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content describes receipt of a GST notice (Form GST ASMT-10) from the Goods and Service Tax Authority regarding a demand for GST liabilities for the period 2021-2022. The letter states the company will respond within prescribed timelines and will update the stock exchanges of any material developments. The document is a regulatory disclosure about a legal/tax notice and does not contain financial statements, audit results, or detailed financial data. It is a compliance announcement under SEBI regulations about a legal proceeding or regulatory action. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-02-12 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure addressed to stock exchanges (National Stock Exchange of India and Bombay Stock Exchange) under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It provides details about a notice received from the Goods and Service Tax (GST) Authority regarding a demand notice for GST liabilities for the period 2022-2023. The document states the company will respond to the notice and update the exchanges of any material developments. The content is a regulatory announcement about a legal/tax matter, not a full report or financial statement. It does not contain financial statements or detailed financial analysis, nor is it a certification or a report publication announcement. It fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance disclosure that does not fit other categories.
2025-02-11 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (NSE and BSE) disclosing information under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements. It references a Show Cause Notice (SCN) received from a tax authority and subsequent order dropping the proceedings. The document provides details about the regulatory action and its impact, which is stated to be none. The document is a regulatory disclosure about a legal/tax matter and does not contain financial statements, earnings data, or detailed management discussion. It is not a full report but a regulatory announcement of a legal proceeding resolution. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-02-06 English
Credit Rating- Revision
Interest Rate Update/Notice Classification · 95% confidence The document is an official communication addressed to stock exchanges regarding a revision in the company's credit rating by ICRA Limited. It references SEBI regulations and provides details of the revised credit ratings along with a rationale annexure explaining the downgrade. The document is a notification about a credit rating update, not a full financial report, earnings release, or audit report. It does not contain comprehensive financial statements or detailed management discussion but serves as a regulatory disclosure about credit rating changes. This fits best under the category of Interest Rate Update/Notice (IRAT), as credit rating revisions impact the company's debt and financial instruments. The document length is 3720 characters, relatively short, and it is a direct announcement rather than a report publication announcement or certification. Therefore, the classification is IRAT with high confidence.
2025-01-31 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 100% confidence The document is a transcript of an earnings conference call held on January 21, 2025, discussing the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2024. It includes detailed management commentary, financial performance data, and a Q&A session with analysts. The presence of a full transcript of the call, including management remarks and participant questions, clearly identifies this as a Call Transcript (CT). The document is lengthy (15,000 characters) and contains substantive content beyond a mere announcement or summary, confirming it is not an Earnings Release (ER) or Regulatory Filing (RNS).
2025-01-24 English
Copy of Newspaper Publication
Regulatory Filings
2025-01-22 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.